Intensity-modulated proton therapy reduces the dose to normal tissue compared with intensity-modulated radiation therapy or passive scattering proton therapy and enables individualized radical radiotherapy for extensive stage IIIB non-small-cell lun

Intensity-modulated proton therapy reduces the dose to normal tissue compared with intensity-modulated radiation therapy or passive scattering proton therapy and enables individualized radical radiotherapy for extensive stage IIIB non-small-cell lun

Item

http://www.wikidata.org/entity/Q33843608

Q33843608

about

Intensity-modulated radiotherapy, not 3 dimensional conformal, is the preferred technique for treating locally advanced lung cancer Particle therapy for non-small cell lung tumors: where do we stand? A systematic review of the literature A critical review of recent developments in radiotherapy for non-small cell lung cancer Beyond Gaussians: a study of single-spot modeling for scanning proton dose calculation Sparsity constrained split feasibility for dose-volume constraints in inverse planning of intensity-modulated photon or proton therapy.Proton therapy in clinical practice Assessing the robustness of passive scattering proton therapy with regard to local recurrence in stage III non-small cell lung cancer: a secondary analysis of a phase II trial.Advances in radiotherapy techniques and delivery for non-small cell lung cancer: benefits of intensity-modulated radiation therapy, proton therapy, and stereotactic body radiation therapy.Improving radiation conformality in the treatment of non-small cell lung cancer.Proton stereotactic body radiation therapy for clinically challenging cases of centrally and superiorly located stage I non-small-cell lung cancer.Oral complications of cancer and cancer therapy: from cancer treatment to survivorship.Radioluminescence characterization of in situ x-ray nanodosimeters: Potential real-time monitors and modulators of external beam radiation therapy Clinical implementation of intensity modulated proton therapy for thoracic malignancies.Superior sulcus non small cell lung carcinoma: retrospective analysis of 42 patients Toxicity and patterns of failure of adaptive/ablative proton therapy for early-stage, medically inoperable non-small cell lung cancer.Impact of respiratory motion on worst-case scenario optimized intensity modulated proton therapy for lung cancers.Proton energy optimization and reduction for intensity-modulated proton therapy Phase 2 study of high-dose proton therapy with concurrent chemotherapy for unresectable stage III nonsmall cell lung cancer.Robust optimization in intensity-modulated proton therapy to account for anatomy changes in lung cancer patients.Which technique for radiation is most beneficial for patients with locally advanced cervical cancer? Intensity modulated proton therapy versus intensity modulated photon treatment, helical tomotherapy and volumetric arc therapy for primary radiation Motion mitigation for lung cancer patients treated with active scanning proton therapy Intensity-modulated proton therapy for elective nodal irradiation and involved-field radiation in the definitive treatment of locally advanced non-small-cell lung cancer: a dosimetric study.Robust optimization of intensity modulated proton therapy.Potential targets for intervention in radiation-induced heart disease.Radiation Dose Escalation in Stage III Non-Small-Cell Lung Cancer.Influence of robust optimization in intensity-modulated proton therapy with different dose delivery techniques Adaptive/nonadaptive proton radiation planning and outcomes in a phase II trial for locally advanced non-small cell lung cancer.FDG uptake correlates with recurrence and survival after treatment of unresectable stage III non-small cell lung cancer with high-dose proton therapy and chemotherapy Exploratory Study of 4D versus 3D Robust Optimization in Intensity Modulated Proton Therapy for Lung Cancer.Motion interplay as a function of patient parameters and spot size in spot scanning proton therapy for lung cancer Combined hyperthermia and radiotherapy for the treatment of cancer.Effects of respiratory motion on passively scattered proton therapy versus intensity modulated photon therapy for stage III lung cancer: are proton plans more sensitive to breathing motion?Comparison of proton therapy techniques for treatment of the whole brain as a component of craniospinal radiation.A novel technique for image-guided local heart irradiation in the rat Cost-effectiveness studies in radiation therapy.Cardiac side effects of conventional and particle radiotherapy in cancer patients.Status of particle therapy for lung cancer.Strategies of dose escalation in the treatment of locally advanced non-small cell lung cancer: image guidance and beyond.Proton beam therapy for locally advanced lung cancer: A review.Dose escalation for unresectable locally advanced non-small cell lung cancer: end of the line?

P2860

Q26851310-84C5877F-98FA-4A36-97F9-54341D742399 Q27023426-A8B85342-4FC1-42FA-8246-7C470887EF7E Q28079625-CC6BAA69-47C9-490B-A998-A170649A3F17 Q28662236-AB847BB7-A842-4141-952C-817D84328417 Q33276446-F72AC734-E094-4D8B-B4B8-B7A100282081 Q33579648-F7AAB81A-D6C5-474E-BC27-63B3FD235E33 Q33645532-FD260E8B-33F4-4D33-A4C4-1994632255E5 Q33645619-C46EC587-6737-4B0B-9F5B-A0D9C6CA3170 Q34002179-724D04E7-35E2-43C0-91E1-793A6A9589D3 Q34187098-B3D08767-A1EE-4F68-80A1-B726FCB9BE8C Q34299445-CA08738D-A990-4F0F-95BE-DD5A8B8C4417 Q34558103-9CAE2FE8-2898-4E51-A91E-21823FF96CAE Q34615702-013E50DB-ACCB-42C6-B099-28FBCB39CC1A Q34720546-25ACAD3F-0C2D-4FBD-A806-B7C7A84FDBD4 Q35050966-836B66A7-5911-4C6C-BCD3-B7AC3E77DE07 Q35163969-5B522EA3-19DB-47C8-B4B0-41CE0B9C3B31 Q35212130-911B03B5-C4F3-4423-94AD-84E27E1D8CC2 Q35216097-E35D1B29-C049-4099-A4AA-46F731A0FD2E Q35449770-4CD59F36-155F-4478-9316-C5E1CA3BB0C2 Q35497498-698DE66F-44E8-48D8-91D2-FEAA10DA67CD Q35537591-55465ECE-070A-40F4-854E-608B47BDE925 Q35539141-BB0DC8B0-0DA4-4979-A416-76A96B4F1387 Q35764013-23F086F8-E4CE-4AB4-92F1-85B90FCBCCDA Q35848543-FF464DDE-27A8-4B2E-BFCD-780A8152762F Q35971034-95181051-7DFB-4D4F-815E-30A848E6B4FA Q35989268-6FF7CCDB-616E-4881-B551-180D6916F9E4 Q36133461-EE03DC17-C005-4737-8941-4A08F8C073D5 Q36239986-13F282AB-BE46-4265-B42B-1E59DEBC8121 Q36805626-0277D273-999C-40D6-BA35-C7B20C1CB670 Q36824069-1E451CA6-68A1-4287-BA70-896091D51F4F Q37148144-4677846A-E711-4229-AF5B-EF3976710D4C Q37301157-9AAA91EF-23E3-4B17-A821-76FC58EEC947 Q37431113-FAED7D86-8E3B-40A9-9584-1245AE3361BE Q37633651-00045368-0AD8-4FB1-B40E-E78D52140567 Q37800482-B79A5104-10F3-4721-8209-4386F54BE972 Q37883959-53888EB0-4B04-46DF-83B2-3E3E544C4031 Q37902239-B07C0EEA-BF04-49BD-8650-F716429BB454 Q38226816-4BC265EB-56D5-445A-989A-39DC44C57B6B Q38258751-7E068062-A610-4800-97C9-DF948AED65A6 Q38549486-A72F28E8-5678-40AA-A871-4F574733A3F4

P2860

Intensity-modulated proton therapy reduces the dose to normal tissue compared with intensity-modulated radiation therapy or passive scattering proton therapy and enables individualized radical radiotherapy for extensive stage IIIB non-small-cell lun

Item

http://www.wikidata.org/entity/Q33843608

description

2009 nî lūn-bûn

@nan

2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu